American Century Companies Inc. Grows Position in OraSure Technologies, Inc. $OSUR

American Century Companies Inc. grew its holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) by 6.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,505,124 shares of the medical instruments supplier’s stock after buying an additional 159,287 shares during the period. American Century Companies Inc. owned 3.23% of OraSure Technologies worth $8,442,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Private Management Group Inc. purchased a new stake in OraSure Technologies during the 1st quarter valued at about $14,886,000. Gagnon Securities LLC purchased a new stake in shares of OraSure Technologies in the first quarter valued at approximately $3,619,000. D. E. Shaw & Co. Inc. increased its holdings in shares of OraSure Technologies by 180.5% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,517,541 shares of the medical instruments supplier’s stock valued at $5,478,000 after purchasing an additional 976,475 shares during the last quarter. Gagnon Advisors LLC purchased a new position in OraSure Technologies during the first quarter worth approximately $2,687,000. Finally, Systematic Financial Management LP boosted its stake in OraSure Technologies by 33.7% during the fourth quarter. Systematic Financial Management LP now owns 1,673,609 shares of the medical instruments supplier’s stock worth $6,042,000 after buying an additional 421,497 shares during the last quarter. 93.50% of the stock is currently owned by institutional investors and hedge funds.

OraSure Technologies Trading Up 10.8%

Shares of OSUR opened at $3.48 on Wednesday. The company’s 50-day moving average price is $3.05 and its 200 day moving average price is $3.11. OraSure Technologies, Inc. has a 12-month low of $2.36 and a 12-month high of $4.61. The firm has a market cap of $254.53 million, a P/E ratio of -5.19 and a beta of 0.27.

Analyst Ratings Changes

OSUR has been the topic of several analyst reports. Evercore ISI reiterated an “in-line” rating and set a $3.00 price target on shares of OraSure Technologies in a report on Monday, May 19th. Wall Street Zen upgraded shares of OraSure Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, May 17th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, OraSure Technologies presently has an average rating of “Hold” and a consensus target price of $3.00.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.